Target intelligence / Profile preview

Senescent Cell Antigen (SCA)

Target
SCA
Molecular classification
Glycoprotein, Membrane protein
01

Overview

Senescent cell antigen (SCA) refers to a set of molecular changes or specific antigens appearing on the surface of senescent cells. These antigens are recognized by the immune system and play roles in both the physiological clearance of aged cells and in disease contexts such as cancer and age-related disorders. The classic SCA is a glycosylated polypeptide related to band 3 protein, but other cell types may express different senescence-associated surface markers. Immune recognition via these antigens is central for physiological removal but may also contribute to inflammation if clearance fails. SCAs are being investigated as targets for cancer immunotherapy and other age-related diseases.

Other names
Senescence-associated antigenAged cell antigen
02

Mechanism of action

N/A

03

Biological functions

Immune recognitionCell clearanceAntigen presentation
04

Disease associations

CancerAgingAge-related diseasesInflammation
05

Safety considerations

Potential for off-target effects in therapies targeting senescent cellsRisk of inducing autoimmunity if immune responses are not tightly controlled
06

Biomarkers

Surface expression on senescent cells

Beyond the preview

Go deeper on Senescent Cell Antigen (SCA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Senescent Cell Antigen (SCA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call